SNCA and Parkinson disease: In the early stage of Parkinson disease, soluble alpha-synuclein fibrils are thought to exert neurotoxic effects, and they may act as a TLR4 ligand to induce neuroinflammation in microglia and astrocytes, leading to further neurological damage [10,11,95,96,112,113].